GlassScriptPhysician profile
Matthew Michael Bowersox
NPI 1912388307
$45,998.26
in general payments reported to CMS, 2019-2025
19 companies · $1,386 in 2025
The $1,386 reported for 2025 was more than what 75% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $35K · 2020: $2,658 · 2021: $2,518 · 2022: $1,739 · 2023: $1,879 · 2024: $1,228 · 2025: $1,386.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,492.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,492.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $30,502.99 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Abbott Laboratories | $7,570.18 | 2019-2025 | Proclaim, Eterna, Octrode |
| Nevro Corp. | $4,145.65 | 2019-2023 | Senza |
| Biotronik Nro, INC. | $787.10 | 2024-2025 | Prospera |
| Spr Therapeutics, INC | $655.82 | 2021-2025 | Sprint Pns System |
| Medtronic USA, INC. | $630.54 | 2019-2020 | |
| Nalu Medical, INC. | $506.78 | 2021-2024 | Nalu Neurostimulation System |
| Vertos Medical, INC. | $451.52 | 2022-2024 | Mild Device Kit |
| Medtronic, INC. | $172.08 | 2021-2024 | Bis, Intellis Adaptivestim |
| Vertiflex, INC. | $138.46 | 2019 | |
| Flowonix Medical Incorporated | $130.30 | 2019 | |
| Tersera Therapeutics LLC | $123.85 | 2025 | Prialt |
| Merck Sharp & Dohme LLC | $51.06 | 2025 | Bridion |
| Stryker Corporation | $34.30 | 2021 | |
| Relievant Medsystems, INC. | $24.91 | 2023 | Intracept |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $23.85 | 2024 | |
| Painteq LLC | $23.76 | 2023 | Painteq |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.00 | 2019 | |
| Saluda Medical Americas, INC. | $10.11 | 2023 | Evoke Scs |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Bowersox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.